CIK 0001069530
- Non-accelerated filer
- Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911911336
- Phone
- +1 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $627,549
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$627,549. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-09-12 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualifying Stock Options | +15,000 | $8.56 | $128K | 80,000 |
| 2008-09-12 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options | +15,000 | $8.56 | $128K | 365,000 |
| 2008-09-12 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options | +15,000 | $8.56 | $128K | 265,000 |
| 2008-09-03 | BARBIER REMI President and CEO | Sale | −25,000 | $9.38 | $235K | 6,850,200 |
| 2008-09-02 | BARBIER REMI President and CEO | Sale | −25,000 | $9.43 | $236K | 6,875,200 |
| 2008-08-04 | BARBIER REMI President and CEO | Sale | −25,000 | $8.35 | $209K | 6,775,200 |
| 2008-08-01 | FRIEDMANN NADAV Chief Operating & Med. Officer | Purchase | +25,000 | 233,572 | ||
| 2008-08-01 | BARBIER REMI President and CEO | Sale | −25,000 | $8.33 | $208K | 6,800,200 |
| 2008-08-01 | BARBIER REMI President and CEO | Purchase | +125,000 | 6,900,200 | ||
| 2008-07-02 | BARBIER REMI President and CEO | Sale | −25,000 | $7.65 | $191K | 6,825,200 |
| 2008-07-01 | BARBIER REMI President and CEO | Sale | −25,000 | $7.76 | $194K | 6,850,200 |
| 2008-06-13 | FRIEDMANN NADAV Chief Operating & Med. Officer | Grant or award · Stock Options | +300,000 | $7.51 | $2.3M | 2,010,000 |
| 2008-06-13 | BARBIER REMI President and CEO | Grant or award · Stock Options | +325,000 | $7.51 | $2.4M | 2,401,500 |
| 2008-06-13 | SCHOENHARD GRANT Chief Scientific Officer | Grant or award · Stock Options | +75,000 | $7.51 | $563K | 675,000 |
| 2008-06-13 | RODDY PETER S Vice President and CFO | Grant or award · Stock Options | +125,000 | $7.51 | $939K | 690,000 |
| 2008-06-03 | BARBIER REMI President and CEO | Sale | −25,000 | $8.07 | $202K | 6,875,200 |
| 2008-06-02 | BARBIER REMI President and CEO | Sale | −25,000 | $8.01 | $200K | 6,900,200 |
| 2008-05-22 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualifying Stock Options | +25,000 | $8.15 | $204K | 65,000 |
| 2008-05-22 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options | +25,000 | $8.15 | $204K | 350,000 |
| 2008-05-22 | O DONNELL MICHAEL J Director | Grant or award · Non-Qualifying Stock Options | +25,000 | $8.15 | $204K | 225,000 |
Page 34 of 38 · 751 trades